Washington, May 13 : Queen’’s University scientists have created a new way of performing lab tests that could improve the way doctors manage prostate cancer treatment.
It will allow them to identify with unprecedented accuracy losses of a gene called PTEN that is associated with an aggressive group of prostate cancers.
The improved Fluorescence In-Situ Hybridization (FISH) [...]
London, May 1 : Provenge, the world’s first prostate cancer ”vaccine” which works by boosting the body’s immune system to fight tumours, is to be used in patients.
The vaccine helps those already in an advanced stage of the disease.
According to medical tests, it can prolong the life of terminal patients by around four months, one [...]
Washington, Apr 24 : The more of a man’’s direct relatives, i.e. brothers and fathers, are affected with prostate cancer, the higher is his personal risk to develop the disease himself, claims a study.
Researchers of the department headed by Kari Hemminki at DKFZ have studied how high is an individual person’’s risk in familial prostate [...]
Washington, Apr 20 : Johns Hopkins boffins have evaluated a simple, more specific blood test that identifies patients undergoing proactive surveillance for low-grade, low-stage, non-palpable prostate cancer who would eventually require treatment.
The results, presented at the American Association for Cancer Research 101st Annual Meeting 2010, may be a major advance in prostate cancer risk assessment.
“Finding [...]
Washington, April 17 : Researchers at the University of Cincinnati are set to test targeted treatment for prostate cancer.
The partnership with Areva Med will see UC scientists using the lab of Zhongyun Dong, PhD, to test the efficacy of a new agent targeted against a specific protein on the surface of the tumour.
Dong, an associate [...]
London, April 14 : A new research has shown that having prostate cancer can more than double a man’’s chances of suffering blood clots in his legs or lungs.
The study of 76,000 Swedish men, conducted by researchers at King’s College London, also showed that the blood clot risk is greatest for men undergoing hormone therapy [...]
Washington, Apr 2 : Some drugs, known to fight HIV, also inhibit a retrovirus recently linked to prostate cancer and chronic fatigue syndrome (CFS), according to a new study from University of Utah and Emory University/Veterans Affair Medical Center (VA) researchers.
The finding means that if the retrovirus XMRV (Xenotropic murine leukemia virus-related virus) is proved [...]
Washington, March 10 (ANI): Scientists in Canada are working on a new way to treat prostate cancer using a virus.
In the study, researchers administered the virus to six volunteer patients and found that it killed off cancer cells while sparing normal tissue.
According to the study, the respiratory, enteric, orphan virus (commonly known as reovirus) is [...]
Washington, Feb 26 (ANI): Monash University researchers have discovered a new way to treat castrate resistant cells in prostate cancer patients.
The findings of the study, conducted by scientists from the Prostate & Breast Cancer Research Program, have appeared in the medical journal PNAS.
Associate Dean, Research Centres & Institutes and co-author Professor Gail Risbridger said: “The [...]
Washington, Feb 3 : A new research suggests that a prostate cancer diagnosis carries an immediate risk of suicide and cardiovascular death.
Fang Fang of the Channing Laboratory, Department of Medicine, Brigham and Women’’s Hospital, Harvard Medical School, in Boston, and colleagues analysed data from more than 340,000 prostate cancer patients listed in the Surveillance, Epidemiology, [...]